Association of Genetic and Environmental Risks for Attention-Deficit/Hyperactivity Disorder With Hypomanic Symptoms in Youths. Hosang Georgina M et al. JAMA psychiatry 2019 Aug

Main|Search|PHGKB






Last Posted: Aug 15, 2019

---

• Association of Genetic and Environmental Risks for Attention-Deficit/Hyperactivity Disorder With Hypomanic Symptoms in Youths.
  Hosang Georgina M et al. JAMA psychiatry 2019 Aug
• Examining the Importance of Family History in Pediatric Behavioural Referrals.
  Gander Sarah et al. Cureus 2019 May 11(5) e4790
• Use of deep learning to detect personalized spatial-frequency anomalies in EEGs of children with ADHD.
  Chen He et al. Journal of neural engineering 2019 Aug
• Psychiatric Polygenic Risk Scores as Predictor for Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in a Clinical Child and Adolescent Sample.
  Jansen Arija G et al. Behavior genetics 2019 Jul
• Genotype-phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study.
  Chawner Samuel J R A et al. The lancet. Psychiatry 2019 May
• Association of Rare Copy Number Variants With Risk of Depression.
  Kendall Kimberley Marie, et al. JAMA psychiatry 2019 4 0.
• Autism Spectrum Disorders and ADHD: Overlapping Phenomenology, Diagnostic Issues, and Treatment Considerations.
  Antshel Kevin M et al. Current psychiatry reports 2019 Mar 21(5) 34
• Family History of Mental and Neurological Disorders and Risk of Autism.
  Xie Sherlly, et al. JAMA network open 2019 3 0. (3) e190154
• Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Atomoxetine Therapy.
  Brown Jacob T et al. Clinical pharmacology and therapeutics 2019 Feb
• Sibling Recurrence Risk and Cross-aggregation of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.
  Miller Meghan et al. JAMA pediatrics 2018 Dec

more